Last reviewed · How we verify
NCT05815784
Myopia Control: a Comparison Study Between Atropine and MiSight
Phase 2 trial testing Atropine in Myopia in 348 participants. Currently enrolling.
13 March 2026
Quick facts
| Lead sponsor | Ann & Robert H Lurie Children's Hospital of Chicago |
|---|---|
| Phase | Phase 2 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 348 |
| Start date | 2 May 2023 |
| Primary completion | 13 March 2026 |
| Estimated completion | 13 March 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Atropine (ATROPINE) — full drug profile →
- MiSight contact lenses
Conditions studied
- Myopia — all drugs for Myopia →
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Who can join
Adults 5 to 12, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research project aims to provide additional knowledge of pharmacological and optical methods of myopia control and to gain a better understanding of the biometry of the pediatric eye, which contributes to the onset and progression of myopia. As a result, this study will improving our best practices for myopia control in pediatric patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05815784
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Atropine
Trials testing the same drug.
- NCT07095894 — A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control · Phase 3 · not yet recruiting
- NCT06111352 — Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime · Phase 2 · completed
- NCT05203432 — Red Light Intervention on Myopic Progression · NA · unknown
- NCT04699357 — The Effect and Safety of Different Doses of Atropine on Myopic Progression of Highly Myopic Children: Multi-centered Ran · NA · completed
- NCT03972683 — Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training · EARLY_PHASE1 · withdrawn
Other recruiting trials for Myopia
Currently open trials in the same condition.
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
- NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
- NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
- NCT07229365 — Children's Viewing Behavior · NA · recruiting
Other Ann & Robert H Lurie Children's Hospital of Chicago trials
Trials by the same sponsor.
- NCT07411300 — Supporting Caregivers Following Mental Health Emergency Department Visits · NA · recruiting
- NCT06986148 — Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP) · NA · recruiting
- NCT07372898 — Impact of Hospital to Home: Optimizing Preterm Infant Environment for Surgical Neonates and Their Parents (H-HOPE) · NA · recruiting
- NCT07216326 — Our Voices Matter: Intervention for Depression in Youth · NA · recruiting
- NCT06689943 — Pain After Strabismus Surgery · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05815784 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ann & Robert H Lurie Children's Hospital of Chicago
- Last refreshed: 19 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05815784.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing